Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-13
2000-01-04
Jones, Dwayne C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514414, 514569, 514570, A01N 4338
Patent
active
060110554
ABSTRACT:
A method for treating polycystic kidney disease in an individual in need thereof. This method includes identifying a mammal having a cystic disease and administering to the mammal a pharmacologically effective anti-cystic amount of TNF-.alpha. or an agent which stimulates TNF-.alpha. production in vivo. The agent is administered in a pharmacologically acceptable carrier, excipient or diluent.
REFERENCES:
T. Akimoto, et al. (1994) "Antitumor Effect Of DT-5641a, A Synthetic Low-Toxicity Lipid A Analog, Involves Endogenous Tumor Necrosis Factor Induction Subsequent To Macrophage Activation", Int. J. Immunopharmac., 16(11):887-893.
E.D. Avner, et al. (1992) "Abnormal Sodium Pump Distribution During Renal Tubulogenesis In Congenital Murine Polycystic Kidney Disease", Proc. Natl. Acad. Sci. USA, 89:7447-7451.
B. Beutler, et al. (1994) "Unraveling Function In The TNF Ligand And Receptor Families", Science 264:667-668.
A.P. Bollon, et al. (1988) "Human Cytokines, Tumor Necrosis Factor, And Interferons: Gene Cloning, Animal Studies, And Clinical Trials", Journal of Cellular Biochemistry, 36:353-367.
E.A. Carswell, et al. (1975) "An Endotoxin-Induced Serum Factor That Causes Necrosis Of Tumors", Proc. Nat. Acad. Sci. USA, 72(9):3666-3670.
B.D. Cowley, et al. (1991) "Elevated Proto-Oncogene Expression In Polycystic Kidneys Of The C57BL/6J (CPK) Mouse", J. Am. Soc. Nephrol., 1:1048-1053.
M.C. Daoust, et al. (1995) "Evidence For A Third Genetic Locus For Autosomal Dominant Polycystic Kidney Disease", Genomics, 25:733-736.
M.T. Davisson, et al. (1991) "The Mouse Polycystic Kidney Disease Mutation (cpk) Is Located On Proximal Chromosome 12", Genomics, 9:778-781.
I. Ebihara, et al. (1988) "Altered mRNA Expression Of Basement Membrane Components In A Murine Model Of Polycystic Kidney Disease", Laboratory Investigation, 58(3):262-269.
V.H. Gattone II, et al. (1991) "Murine Infantile Polycystic Kidney Disease: A Role For Reduced Renal EpidermalGrowth Factor", American Jour. of Kidney Diseases, XVII(6):606-607.
S. Golding, et al. (1995) "Tenidap-Modulated Proinflammatory Cytokine Activation Of A Monocyte Cell Line", The Journal of Immunology, 154:5384-5390.
D.E. Griswold, et al. (1993) "Differentiation In Vivo Of Classical Non-Steroidal Antiinflammatory Drugs From Cytokine Suppressive Antiinflammatory Drugs And Other Pharmacological Classes Using Mouse Tumour Necrosis Factor Alpha Production", Drugs Exptl. Clin. Res., XIX(6):243-248.
M.A. Harding, et al. (1991) "The SGP-2 Gene Is Developmentally Regulated In The Mouse Kidney And Abnormally Expressed In Collecting Duct Cysts In Polycystic Kidney Disease", Devel. Biol. 146:483-490.
S. Horikoshi, et al. (1991) "Epidermal Growth Factor (EGF) Expression In The Congenital Polycystic Mouse Kidney", Kidney International, 39:57-62.
W.J. Kimberling, et al. (1993) "Autosomal Dominant Polycystic Kidney Disease: Localization Of The Second Gene To Chromosome 4q13-q23", Genomics, 18:467-472.
J. Mandell, M.D., et al. (1993) "Animal Model Of Human Disease: Congential Polycystic Kidney Disease", Am. J. Pathol., 113(1):112-114.
D.F. Mangan, et al. (1991) "Lipopolysaccharide, Tumor Necrosis Factor-.alpha., And IL-1.beta. Prevent Programmed Cell Death (Apoptosis) In Human Peripheral Blood Monocytes.sup.1 ", The Journal of Immunology, 146:1541-1546.
R.A. McDonald, et al. (1991) "Inherited Polycystic Kidney Disease In Children", Seminars in Nephrology, 11(6):632-642.
S.A. Orellana, et al. (1995) "Epidermal Growth Factor Receptor Expression Is Abnormal In Murine Polycystic Kidney", Kidney International, 47:490-499.
G.M. Preminger, M.D., et al. (1982) "Murine Congenital Polycystic Kidney Disease: A Model For Studying Development Of Cystic Disease", The Journal of Urology, 127:556-560.
S.T. Reeders, et al. (1985) "A Highly Polymorphic DNA Marker Linked To Adult Polycystic Kidney Disease On Chromosome 16", Nature, 317:542-544.
M.J. Reiter, et al. (1994) "Cytokine Induction In Mice By The Immunomodulator Imiquimod", Journal of Leukocyte Biology, 55:234-240.
M. Taub. et al. (1990) "Altered Basement Membrane Protein Biosynthesis By Primary Cultures Of CPK/CPK Mouse Kidney", Kidney International, 37:1090-1097.
M. Tsujimoto, et al. (1985) "Tumor Necrosis Factor: Specific Binding And Internalization In Sensitive And Resistant Cells", Proc. Natl. Acad. Sci. USA, 82:7626-7630.
B.B. Warner, et al. (1991) "Tumor Necrosis Factor-.alpha. Increases Mn-SOD Expression: Protection Against Oxidant Injury", The American Physiological Society, L296-L301.
G.H.W. Wong, et al. (1988) "Induction Of Manganous Superoxide Dismutase By Tumor Necrosis Factor: Possible Protective Mechanism", Science, 242:941-944.
D.D. L. Woo, et al. (1994) "Taxol Inhibits Progression Of Congenital Polycystic Kidney Disease", Nature, 368:750-573.
D. Woo, Ph.D. (1995) "Apoptosis And Loss Of Renal Tissue In Polycystic Kidney Diseases", The New England Journal Of Medicine, 333(1):18-25.
K. Zerres, et al. (1994) "Mapping Of The Gene For Autosomal Recessive Polycystic Kidney DIsease (ARPKD) To Chromosome 6p21-cen", Nature Genetics, 7:429-432.
D. Woo, Ph.D. (1994) "Taxol Inhibits Progression Of Progression Of Congenital Polycystic Kidney Disease", Nature 368:750-753.
Jones Dwayne C.
The Regents of the University of California
LandOfFree
Treatment of cystic disease with compounds which stimulate TNF-. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of cystic disease with compounds which stimulate TNF-., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cystic disease with compounds which stimulate TNF-. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1072969